Shanghai Universal Biotech Co.,Ltd. (SHE:301166)

SHE:301166 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	407.51	840.16	414.53	732.14	1,873	250.63
Short-Term Investments	-	-	-	50.76	-	-
Trading Asset Securities	952.11	565.23	1,062	901.24	-	-
Cash & Short-Term Investments	1,360	1,405	1,476	1,684	1,873	250.63
Cash Growth	-3.32%	-4.80%	-12.34%	-10.08%	647.25%	23.61%
Accounts Receivable	353.34	350.56	361.81	375.78	264.79	239.49
Other Receivables	3.79	20.5	17.46	14.35	8.67	2.44
Receivables	357.13	371.06	379.28	390.13	273.46	241.94
Inventory	133.9	129.51	201.54	168.32	77.35	44.62
Other Current Assets	26.83	31.17	32.35	66.11	31.69	12.75
Total Current Assets	1,877	1,937	2,089	2,309	2,255	549.93
Property, Plant & Equipment	222.23	225.47	194.83	102.43	34.91	26.53
Long-Term Investments	48.73	54.81	31.66	27.5	-	-
Other Intangible Assets	10.18	10.52	8.54	7.57	6.13	0.86
Long-Term Deferred Tax Assets	84.12	76.3	59.14	33.71	15.17	11.77
Long-Term Deferred Charges	4.83	4.96	7.7	4.34	1.4	0.55
Other Long-Term Assets	0.11	0.22	0.09	-	0.09	1.21
Total Assets	2,248	2,309	2,391	2,484	2,313	590.85
Accounts Payable	63.33	95.39	110.58	76.04	83.54	63.84
Accrued Expenses	22.09	38.04	43.01	34.88	38.88	31.1
Short-Term Debt	-	-	-	80	-	10
Current Portion of Leases	5.76	5.94	-	-	-	-
Current Income Taxes Payable	9.33	6.61	7.43	10.08	10.47	7.85
Current Unearned Revenue	63.5	69.44	74.32	80.72	69.24	60.39
Other Current Liabilities	10	7.21	6.29	13.17	16.22	11.82
Total Current Liabilities	174.01	222.63	241.63	294.9	218.35	185.01
Long-Term Leases	10.94	11.38	23.46	23.19	4.58	-
Long-Term Unearned Revenue	-	-	-	0.01	0.02	0.04
Long-Term Deferred Tax Liabilities	4.09	3.92	6.18	6.07	-	-
Other Long-Term Liabilities	3.66	3.59	2.96	2.62	1.84	1.01
Total Liabilities	192.7	241.52	274.23	326.77	224.8	186.06
Common Stock	86.67	86.67	86.67	86.67	86.67	65
Additional Paid-In Capital	1,715	1,715	1,715	1,719	1,715	141.36
Retained Earnings	276.39	282.6	313.17	350.85	287.73	199.16
Treasury Stock	-26	-19.5	-	-	-	-
Comprehensive Income & Other	2.7	2.92	2.09	1.37	-1.36	-0.73
Shareholders' Equity	2,055	2,068	2,117	2,157	2,088	404.79
Total Liabilities & Equity	2,248	2,309	2,391	2,484	2,313	590.85
Total Debt	16.69	17.32	23.46	103.19	4.58	10
Net Cash (Debt)	1,343	1,388	1,453	1,581	1,868	240.63
Net Cash Growth	-2.93%	-4.46%	-8.11%	-15.38%	676.40%	54.20%
Net Cash Per Share	15.79	16.41	16.94	18.24	28.52	3.71
Filing Date Shares Outstanding	85.74	85.74	86.63	86.67	86.67	65
Total Common Shares Outstanding	85.74	85.98	86.67	86.67	86.67	65
Working Capital	1,703	1,715	1,848	2,014	2,037	364.92
Book Value Per Share	23.97	24.05	24.43	24.89	24.10	6.23
Tangible Book Value	2,045	2,057	2,109	2,150	2,082	403.93
Tangible Book Value Per Share	23.85	23.93	24.33	24.81	24.02	6.21
Buildings	-	183.97	34.36	34.36	-	-
Machinery	-	75.52	59.39	36.54	20.23	16.38
Construction In Progress	-	2.19	118.43	39.39	2.21	0.42

Updated Oct 28, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.